ClinicalTrials.gg

GNI Group Ltd. clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 26 studies whose lead sponsor is GNI Group Ltd. or one of 1 company grouped under it. 7 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 21, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Compare GNI Group with AstraZeneca and Jiangsu HengRui Medicine →

Pipeline: 4 programs

Each counted once: 4 with a study GNI Group Ltd. leads registered in the last two years.

  • Phase 1
  • Phase 3

The 2 phase-3 programs — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of GNI Group Ltd.’s own registered studies; GNI Group Ltd.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs GNI Group Ltd.’s studies test, most open studies first — 3 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

2 of GNI Group Ltd.’s studies under way reach primary completion within a year, 1 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 2D
  3. J’27
  4. F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. N

Add all 2 to your calendar (.ics) → With an account.

All 26 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now727%Recruiting 6 · Not yet recruiting 1
  • Completed1558%
  • Status unknown or other415%

Phase

  • Phase 112
  • Phase 38
  • Phase 26

Where

Over the years

  1. 15
  2. 16
  3. 17
  4. 18
  5. 19
  6. 20
  7. 21
  8. 22
  9. 23
  10. 24
  11. 25
  12. 826

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to GNI Group Ltd..

  • Beijing Continent Pharmaceutical Co, Ltd.
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    26 studies →

Studies

Recruiting first, then most recently updated. Showing 26 of 26.